Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Avoid contact during pregnancy and breast feeding
Table of contents Alveus Therapeutics Founded: 2024 Technology / disease area: Next-generation therapies for obesity and metabolic diseases Lead candidate: ALV-100 Alveus Therapeutics is a Philadelphia-headquartered metabolic disease biotech company with operations in Copenhagen, built around the idea that obesity drugs leave persistent gaps in durability, tolerability, and long-term adherence
When to seek medical help : Contact your GP before starting berberine if you have any chronic health conditions or take regular medications
Are GLP-1 Medications Safe
US$ 21.80
US$ 29.15
US$ 20.09
US$ 20.54
US$ 27.01
US$ 25.89
US$ 29.29
US$ 24.10
US$ 22.66
